retatrutide clinical trials south africa My Resa - RETATRUTIDE HAS NOT

Recent research has pushed back on muscle loss concerns with these drugs and in average middle-aged trial participants, the data is somewhat reassuring

Billions in research investment

Yes, pharmaceutical companies are developing additional dual and triple agonist medications

Semaglutide Safety for Patients Without a Gallbladder Research indicates that GLP-1 receptor agonists like semaglutide are generally safe for patients with prior gallbladder removal

ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly prescribed for type 2 diabetes and obesity, have demonstrated potential anti-inflammatory and immunomodulatory effects that may be beneficial in chronic inflammatory skin conditions such as psoriasis and hidradenitis suppurativa (HS)

June 19, 2025: Ozempic Doubles the Risk of Vision Loss from Rare Eye Condition The European Medical Agency (which functions like the FDA in the United States) has issued a chilling warning about Ozempic